SUMMARY The varicella zoster virus (VZV) and herpes simplex virus (HSV) IgGI-4 subclasses were compared in serum and cerebrospinal fluid (CSF) of 22 patients with VZV-associated neurological symptoms, 12 patients with HSV-associated neurological symptoms and 14 controls. The clinical syndromes of the VZV-associated diseases comprised meningo-encephalitis, myelitis, myelopathies and polyneuropathies, mostly with a favourable outcome. A characteristic finding was an intrathecal synthesis of VZV IgGl and HSV-3. Commonly also IgG2 and 4 were seen in CSF of VZV patients. 
Varicella zoster virus (VZV) causes chicken-pox in children and herpes zoster in the elderly. Overt neurological disease is less common but subtle findings of CNS involvement are readily detectable. Gibbs et al found an abnormal EEG in 22% of uncomplicated cases of varicella.' Neurological complications of varicella infections, primary and reactivated, include meningitis, encephalitis, myelitis and post-infectious polyradiculopathy.2-5 Meningitis, encephalitis and some cases of myelitis are thought to reflect a viral CNS infection, while myelo-radiculopathy, late cerebellar signs (with prominent vertigo and ataxia) and polyneuropathy are post-infectious complications.56 A rare complication of ophthalmic zoster associated VZV meningoencephalitis is an arteritis of the cerebral vessels that can cause ischaemic damage to the brain.78
In herpes simplex encephalitis (HSVE), the intrathecal herpes simplex virus (HSV) specific IgG is dominated by IgGI but almost all HSVE patients also have IgG3 and sometimes IgG4.9 These patients often show a concomitant IgGI restricted intrathecal VZV IgG synthesis. The common finding of stimulated VZV and HSV IgG synthesis in HSV and VZV infections of the CNS warrants further studies to differentiate antigen specific and non-specific responses. For this reason Control patients VZV IgGI was found in all 14 sera and in nine CSF samples. VZV IgG2 or 3 were not detected in any CSF samples; one control patient had VZV IgG4 in the CSF. HSV IgGl was found in all serum and CSF samples. HSV IgG2 was not found in serum or CSF. Twelve patients had HSV IgG3 and eight had IgG4 in the CSF. Neither specific intrathecal VZV, HSV antibody synthesis nor specific IgM was found in the controls.
Subclass IgG and IgM differences between patient groups Simultaneous anti-HSV IgGl and anti-VZV IgGl synthesis was common in both group I and II, although the IgGl antibody directed against the respective pathogenit virus usually showed higher OD values than the non-specific IgGl. Quantitative analysis of intrathecally synthesised anti-VZV and anti-HSV IgG would have allowed a correct diagnosis only in 12/36 patients from groups I and II. In particular, the detection of intrathecally synthesised VZV IgGl was similar in groups I and II (p > 0-9, Fisher's exact test). A differentiation between the groups was, however, possible by analysis ofanti-VZV and HSV IgG subclasses. Intrathecal synthesis of two or more VZV or HSV IgG subclasses correlated with the respective pathogen (p < 0-01, Fisher's exact test). A combination of the two analyses (first total IgG followed, if necessary, by IgG subclasses) allowed a diagnosis in 33/36 of the patients. Of the remaining patients, only early samples were available from two and late samples from one. Further, VZV IgM in CSF correlated with intrathecal synthesis ofVZV IgGl and 3 (p < 0 05, Fisher's exact test), while HSV IgM in serum correlated with intrathecal synthesis of HSV IgGl, 3 and 4 in the patients with neurological symptoms. Eight out of 22 patients with VZV disease had both VZV IgM and intrathecally produced VZV IgG3.
Discussion
The present study demonstrated that neurological symptoms of VZV infection were strongly associated with intrathecal synthesis of two or more VZV IgG subclasses. The neurological complications occurred in a close temporal relationship with a clinical and serologically confirmed cutaneous VZV infection in 14/22 patients. In these patients, intrathecally produced IgGI was usually detected already at the onset of neurological symptoms. It was followed by IgG3 and less commonly by IgG2 and IgG4. The results indicated that intrathecal VZV IgGI synthesis was followed by production of VZV IgG3 within two weeks. A concomitant HSV IgG synthesis in these patients was restricted to IgGI. Intrathecally produced VZV IgG3 and IgM appeared simultaneously in CSF from patients with acute meningoencephalitis. This simultaneous occurrence shows that intrathecal VZV IgG3 is a marker of a recent VZV reactivation in CNS, as it is of VZV infection peripherally. " We found intrathecally produced VZV IgG subclasses of more than one IgG subclass in three of four patients with VZV associated syndromes occurring I month to 3 months after the VZV cutaneous eruption. The fourth patient with polyneuropathy showed intrathecal synthesis also of HSV IgG subclasses. The characteristic VZV IgG subclass development was also found in samples from patients with meningoencephalitis without any known cutaneous VZV infection and in those with a retinal necrosis heralding the meningoencephalitis. Thus, the VZV IgG subclass findings in these patients did not deviate from the findings in the 14 Patients with neurological disease caused by HSV were recently shown to have a multi-IgG subclass anti-HSV response and a concomitant production of VZV IgG restricted to IgGI, intrathecally.9 The restriction ofnon-specific antibody to IgGI was helpful for ruling out a VZV infection in the serological diagnosis of HSVE. In VZV associated disease the VZV and HSV IgG subclass patterns were reversed. We suggest that either of a simultaneous VZV or HSV IgGI response may be due to polyclonal B-cell activation or the few cross-reacting antigens present,'"'5 '9 whereas an IgG multi-subclass response reflects actual antigen stimulation from replicating virus. It was recently shown that in multiple sclerosis, an inflammatory disease with polyclonal B-cell stimulation,'7 the antiviral antibodies synthesised in the CNS are restricted to IgGI .1617 The present study underlined the necessity of studying intrathecal synthesis of anti VZV IgG in the investigation of meningoencephalites, myelopathies and neuropathies. The mere detection of intrathecally synthesised anti-VZV IgG does not necessarily confer diagnostic specificity. VZV and HSV subclass analysis appears to differentiate VZV and HSV infection of the nervous system. IgG subclass analysis also against other antigens will probably aid the future diagnosis of neurological diseases. We suggest that analysis of specific antiviral IgG subclasses should be undertaken if preliminary studies on specific IgG and IgM are inconclusive. The analysis requires an additional Mathiesen, Linde, Olding-Stenkvist, Wahren incubation with subclass specific antibodies; this may seem costly but should be technically feasible at any diagnostic laboratory.
